Articles & Video
Sponsors running multi country trials must guard against bribery
Globalization of drug research has increased the likelihood of bribery according to new analysis, which suggests the risk is greatest for international, multi-center trials.
Pacific Cancer Care to use AI to find trial patients in Deep Lens deal
The Pacific Cancer Care has teamed with patient recruitment specialist Deep Lens to use artificial intelligence technologies to expand its clinical trial programs.
Shift to remote trials accelerating but new hurdles emerging
Most sponsors and CROs are using decentralized trial technology but more data management work needs to be done to take full advantage of the approach according to new research.
Syneos buys RxDataScience citing trials and product lifecycle business
Syneos Health has bought artificial intelligence and analytics firm RxDataScience with decentralized trials and product lifecycles services in mind.
FDA raises concerns about two Indian CROS, calls for study repetition
The US FDA wants several drug firms to repeat studies over concerns about data generated by CROs Synchron Research Services and Panexcell Clinical Lab.
Emmes: Demand for COVID-19 trial service will continue
Emmes predicts demand for COVID-19 related trials and development work will continue as industry seeks to develop treatments for emerging viral variants.
Curavit joins decentralized trials group, predicts demand will keep growing
Curavit has joined the Decentralized Trials & Research Alliance, an industry-backed non-profit organization focused on the promotion of remote studies.
Icon gets €4m from Ireland to build decentralized trial business
The Irish Government has given Icon €4m to boost its decentralized clinical trial and technology business.
Velocity buys VitaLink and NRI to expand US site network
Velocity Clinical Research has bought VitaLink Research and the National Research Institute expanding its network of US trial sites.
Thread launches decentralized trial consulting service
Decentralized trials are here to stay according to tech firm Thread, which has set up a consulting service to help drug developers make best use of the approach.
Syneos buys StudyKIK in latest move to grow decentralized trials business
Syneos Health has acquired clinical trial recruitment firm StudyKIK, citing its recruitment and retention technologies as the driver.
WCG combines Avoca and MCC citing benefits of collaboration
WCG has combined recent acquisition the Avoca Quality Consortium with the Metrics Champion Consortium (MCC), its clinical trial metrics operation.
Pfizer: Trial management and manufacturing key to DMD gene therapy success
Pfizer has stressed the importance of its global trial management as it looks to be first to market with its gene therapy for Duchenne muscular dystrophy (DMD).
Remote working has not hurt clinical trial sector productivity, Tufts
Clinical research staff who switched to remote working as a result of the pandemic maintained productivity levels but felt less connected, according to new research.
Science 37 and Foundation Medicine to speed decentralized trial recruitment
Science 37 and Foundation Medicine have partnered to help drug developers accelerate enrolment in decentralized clinical trials.
MMS launches free support program for ultra-rare diseases
MMS Holdings says a new support scheme will help trial medicines being developed for ultra-rare diseases.
Scope to help new JV Ketabon test oral ketamine for depression
Scope International will manage trials examining an oral formulation of the anesthetic ketamine as a treatment for depression under a contract with newly formed developer Ketabon.
Effective trial data management even more vital during COVID-19, says study
COVID-19 has underlined the importance of efficient, secure data management in clinical trials, according to research by IBM and US-based CRO Veristat.
COVID has set the stage for trials to go digital say researchers
Clinical trials will enter the digital age according to Indian researchers who say the COVID-19 pandemic has finally convinced CROs to swap pen and paper for data.